Compare Microsoft (MSFT) vs 10X Genomics Inc (TXG) Price & Performance

MicrosoftTrade

10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

Microsoft vs 10X Genomics Inc — how do they compare? Microsoft trades at $397 (market cap $2.99T), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Microsoft is far larger — about 545.6× 10X Genomics Inc's market cap, and Microsoft pays a 0.9% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.

	MSFT	TXG
Market Cap	$2.99T	$5.48B
Volume	36,654,621	—
Sector	Technology	Health
52-Week High	$542.07	$45.80
52-Week Low	$352.83	$11.34
Enterprise Value	$2.97T	$5.02B
Dividend Yield	0.9%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Microsoft

Microsoft (MSFT) trades at $397.75, up 1.0% today, with a bullish technical signal from moving averages and strong fundamental performance. Revenue grew to $281.72B in 2025, with net income of $101.83B, and the company has beaten EPS estimates for three consecutive quarters. Analysts maintain an 80.49% buy rating with a consensus price target of $546.70, highlighting AI leadership through Azure and Copilot.

The outlook remains positive given robust earnings growth and AI-driven opportunities, but risks include elevated capital expenditure concerns and competitive pressures. Valuation metrics like a P/E of 23.96 and P/S of 9.43 suggest the stock is fairly priced, supporting a long-term bullish view tempered by near-term volatility.

10X Genomics Inc

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MSFT

Roundhill Magnificent Seven ETF offers equal exposure to top 7 mega-cap tech stocks but with higher risk and cost.24/7 Wall Street · 5 hours agoNeutral Microsoft shifts to AI-driven revenue model amid record $190B capex and strong demand.Seeking Alpha · 5 hours agoBullish OpenAI and Anthropic boost lobbying to $3.17M in Q2 ahead of IPOs and midtermsCNBC · 8 hours agoNeutral View details →

TXG

New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

About Microsoft

Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.